Your session is about to expire
← Back to Search
Genotype-Guided Diet and Exercise for Cardiometabolic Health
Study Summary
This trial will study how well natriuretic peptides (hormones produced by the heart) work in people with a genetic variation that causes lower levels of these peptides.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not take insulin.You agree to follow the rules of the study.I agree to provide samples for genetic testing.I have never had heart failure, a heart attack, or a stroke.I am 18 years old or older.
- Group 1: Experimental: Low NP Genotype Group
- Group 2: Active Comparator: High NP Genotype Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 3 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 3 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants able to join this research endeavor?
"Affirmative, the information found on clinicaltrials.gov reveals that this research is currently recruiting subjects. This study was initially posted on June 1st 2022 and has since been updated to its most recent version as of July 6th 2022. 200 participants are being recruited from just a single site for participation in this trial."
What is the current intake capacity of this research endeavor?
"Confirmed. Clinicaltrials.gov provides evidence of the study's active recruitment status, which began on June 1st 2022 and was last edited 7 days later. The research team is looking for 200 individuals to participate at a single site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- University of Alabama at Birmingham: < 24 hours
Share this study with friends
Copy Link
Messenger